Chapter 2064: A 100-billion-dollar market for hair
Regarding the application of hair follicle cloning and transplantation treatment technology, Wu Hao and the others have actually drawn up a very complete implementation plan, with the ultimate goal of launching this technology into the market within two to three years.
From this summer to autumn, this technology will also be officially put into clinical trials. Sixty to one hundred patients will be recruited initially for phase I clinical trials. After the phase I clinical trials achieve satisfactory results, it will be
Phase II clinical trials will be conducted, and three hundred to five hundred patients will be recruited for further clinical trials.
After the results of the second-phase clinical trial reach the expected goal, it will immediately enter the third-phase clinical trial. Wu Hao and the others plan to expand the number of people in the third-phase clinical trial to more than 1,000 people.
The more people involved in clinical trials, the richer the data collected, and naturally the more accurate it will be. Wu Hao and others certainly hope that the more data in this area, the better, or that is what all pharmaceutical manufacturers think.
However, clinical trials are expensive, so everyone tends to control them within a reasonable range. As long as the drug or treatment technology developed reaches the relevant expected standards, the clinical trial can be ended.
Generally speaking, you can apply for marketing after completing Phase 3 clinical trials. However, for some drugs and technologies, relevant research continues after they are launched, and there may even be Phase 4 or Phase 5 clinical trials.
On the one hand, the purpose is of course to conduct more detailed experiments on this drug or technological achievements, so as to obtain more data and information, such as what kind of curative effect this drug has on what diseases, and what side effects it has on ordinary people and specific groups of people.
Wait, these will take a long time to study.
So you may find that the instructions for some very expensive drugs or some common drugs are very detailed and densely packed with relevant research information about the drug.
On the other hand, it is to explore the maximum value of this drug and technology. For example, the development of some drugs is usually very dramatic. For example, the well-known aphrodisiac drug, Brother W, this drug was originally developed to treat
Heart disease and cardiovascular disease. However, researchers later discovered that this drug has serious side effects. One of the most important side effects is that it easily causes men to become excited and stand up.
As a result, this drug, which was originally used to treat new elders and cardiovascular diseases, has dramatically become a holy medicine for men to regain their power. On the contrary, its original role has been gradually ignored by people.
There are also some drugs that have very good therapeutic effects on different diseases. In other words, one drug can treat many diseases. In this way, the scope of use of this drug will be wider, and the demand will increase exponentially.
Its market returns have naturally increased.
Especially for many pharmaceutical companies, it is not easy to develop a new drug. The investment is huge, time-consuming and labor-intensive. It usually takes five to ten years to produce results, and it may not be successful.
So now that a drug has been developed, these pharmaceutical companies naturally want to tap out the full value of the drug.
As far as this hair follicle cloning and transplantation treatment technology is concerned, its market prospects are definitely very broad. Wu Hao and others once made an estimate that once this technology is put into commercial use, it will bring more than 1,000 to Haoyu Technology.
Market revenue of more than 100 million.
This is definitely a huge market. After all, for all men and women who suffer from hair loss or have hair loss, regaining beautiful black hair is what these people dream of.
"Can the price really be controlled so low? In theory, it seems to be much more complicated than ordinary hair transplantation technology." An expert present who also suffers from some hair loss asked.
After hearing what this expert said, everyone present nodded and looked at Wu Hao. Indeed, they also had such doubts in their minds. In this case, the cloning and transplantation treatment technology of hair follicles should be more complicated. Why is it so complicated?
Ordinary hair transplantation is cheap.
Facing the curious eyes of everyone, Wu Hao said with a smile: "First of all, traditional hair transplant surgery requires the collection and extraction of hair follicles from other parts of the patient. This process is relatively slow, and then the extracted hair follicles need to be processed.
Organize and eliminate some unqualified ones.
Finally, these extracted hair follicles are then transplanted bit by bit into the parts of the patient's head that need to be covered. The entire treatment process is basically manual, which is very time-consuming and labor-intensive, so the cost is naturally high.
As for our technology, it uses automated intelligent medical technology to a large extent. For example, some processes can be completely automated using these surgical instruments. Not only is the operation time shorter and more efficient, but the average quality is better than manual surgery.
The implantation is more stable, which ensures the survival rate of hair transplantation.
And it is also because the addition of automated and unmanned surgical instruments has greatly liberated the doctor's hands, so the corresponding treatment costs have also been significantly reduced."
After hearing Wu Hao's introduction, everyone immediately laughed, but the smiles on the faces of the medical experts present were more or less bitter. When they heard that Wu Hao was going to replace the original hair transplant, they all laughed.
, performing hair transplantation on their behalf is undoubtedly robbing them of their jobs. As colleagues, how can they bear it? At the same time, they also have a great sense of crisis for their professional work.
This sense of crisis did not just appear today. In fact, it has appeared a long time ago. Especially when Wu Hao and others have developed bio-3D printing technology, this has made Xu Shenghua, Zhang Qinghong and other experts more or less feel the same.
There was a slight sense of crisis. The medical technology experience that they had relied on for survival and as a warning seemed to be so vulnerable in the face of new technologies.
And this time, they saw the recovery changes on the patients' faces, which made their sense of crisis even stronger. Maybe one day, they really won't be needed anymore, as long as they have machines and equipment.
You mean that the entire hair transplantation process uses intelligent medical equipment and does not require the participation of doctors. Wu Jiuzhi grasped the core of the problem and looked at Wu Hao for confirmation.
Wu Hao smiled and nodded: "In fact, not only the hair transplantation process, but also the cloning and cultivation process of these hair follicle tissues can be completely handled by robots.
We only need to feed the patient's hair follicle tissue sample into the machine, and the relevant cloning equipment will clone the hair follicle tissue and then cultivate it. After the required amount of cloning culture material is cultivated, the bio-3D printing equipment will be autonomous
Carry out work to print out batches of cloned hair follicles."
